HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N6- benzyl- 5'- N- ethyl- carboxyamidoadenosine

adenosine A3 receptor agonist

Also Known As:

BNECA

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purine Nucleosides: 360
        Adenosine: 12431
        N6-benzyl-5'-N-ethyl-carboxyamidoadenosine: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Purine Nucleosides: 360
    - Adenosine: 12431
      - N6-benzyl-5'-N-ethyl-carboxyamidoadenosine: 1
  - Ribonucleosides: 49
    - Adenosine: 12431
      - N6-benzyl-5'-N-ethyl-carboxyamidoadenosine: 1

Related Diseases

1.

06/01/1996 - "Isolated cells were ischemically preconditioned or pre-incubated for 10 min with increasing concentrations of adenosine, CCPA (2-chloro-N6-cyclopentyladenosine), APNEA (N6-2-(4-aminophenyl)ethyladenosine), or BNECA (N6-benzyl-5'-N-ethyl-carboxamidoadenosine) in the presence or absence of 1 or 10 microM of the selective A1-adenosine antagonist DPCPX (8-Cyclopentyl-1,3-dipropylxanthine). "
06/01/1996 - "Adenosine, CCPA, APNEA, BNECA and DPCPX each appear to be selective for the A1 adenosine receptor subtype in isolated rabbit cardiomyocytes."

Related Drugs and Biologics

1.	Purinergic P1 Receptors (Adenosine Receptor)
2.	Adenosine (Adenocard)
3.	1,3-dipropyl-8-cyclopentylxanthine